Investor mix
2 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 50% |
| Other / undisclosed | 1 | 50% |
Pioneering anti-virulence therapeutics for urinary tract infections and tuberculosis
2 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 50% |
| Other / undisclosed | 1 | 50% |